Healthcare IT Today

APRIL 25, 2024

In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drug development processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.

Pharmaceuticals 137

Pharmaceuticals Drug Development BioTech Life Science 137

Digital Health Global

NOVEMBER 20, 2023

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. They can view historic data and forecast future trends.

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Healthcare IT News - Telehealth

JANUARY 20, 2022

That is the opinion of Ron Emerson, RN, global healthcare lead at Zoom, as he looks ahead at what he believes will be some developments in healthcare in 2022. One example of how video-assisted virtual visits provide easy access for patients is the ability to capture objective data over video without the need for medical devices.

Life Science 203

Life Science Primary Care Mental health Drug Development 203

Healthcare IT Today

NOVEMBER 1, 2022

Financing will be used to accelerate and further diversify COTA’s oncology real-world data products and services. an oncology real-world data and analytics company, announced its latest financing by an investment fund managed by Deerfield Management , a healthcare investment firm. COTA, Inc. ,

Life Science 105

Life Science Drug Development Digital Health Health IT 105

Healthcare IT Today

NOVEMBER 6, 2023

This strategic consolidation establishes PicnicHealth as the leading patient-centric evidence-generation partner within a rapidly evolving life sciences landscape. By combining forces, we can unlock the potential of patient-centered studies and provide best-in-class solutions to support therapeutic development.”

Life Science 121

Life Science Drug Development Patient Experience healthcare technology 121

Digital Health Global

MARCH 29, 2023

Genialis is developing next-generation patient classifiers using machine learning and high-throughput omics data to capture underlying disease biology and predict how patients will likely respond to targeted therapies. ResponderID yields new biomarkers for drug development and discovery programs, as well as diagnostic tests.

Drug Development 128

Drug Development Pharmaceuticals Life Science Digital Health 128

Healthcare IT Today

OCTOBER 6, 2023

The support from our new strategic investors, Presidio and Samsung Next, and international healthcare partners underscores the value we deliver on a global scale– to unlock real-world data for evidence-based medicine.” Atropos’ unique global offerings help life science leaders overcome this challenge.

Life Science 124

Life Science Drug Development Pharmaceuticals Health IT 124

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. The use of DHTs in neurology trials produced consistent benefits on many levels.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Healthcare IT Today

JULY 25, 2022

Cornerstone’s Enterprise platform launches to unlock the power of clinical data in a fraction of the time of traditional methods. Today, Cornerstone AI, a new company solving healthcare’s data challenges to improve research and care, publicly launched its first-of-its-kind AI platform.

Life Science 98

Life Science Drug Development Digital Health Health Data 98

Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Healthcare IT Today

JULY 20, 2023

Flywheel , the leading medical imaging data and AI platform, announces it has raised $54 million in Series D funding with more to come soon. We are particularly excited about the ability of these tools to drive more efficient and faster drug development processes in the biopharma industry.” “The Louis, and Budapest.

Life Science 75

Life Science Drug Development Healthcare Innovation Pharmaceuticals 75

Healthcare IT Today

JANUARY 8, 2024

For the pharmacovigilance space, for example, this automation will begin as a tool for recommendations, suggestions or options for potential safety reports, but it will not fully replace human efforts particularly as there are concerns around data output consistency.

Health IT 93

Health IT Drug Development Pharmaceuticals BioTech 93

The Digital Health Corner

MARCH 26, 2018

1] [6] Each block typically contains a cryptographic hash of the previous block, [6] a timestamp and transaction data. [7] 7] By design, a blockchain is inherently resistant to modification of the data. Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health.

Digital Health 117

Digital Health Interoperability Life Science HIE 117

Healthcare IT Today

MAY 22, 2023

Prognos Health , the largest real-world integrated data marketplace, has announced that it has raised $23 million in growth equity co-led by Marshall Wace and Safeguard Scientifics , with participation from Cigna Ventures , Hikma Ventures , Hunt Holdings , Labcorp , Maywic , Merck Global Health Innovation Fund , and Red and Blue Ventures.

Life Science 69

Life Science Drug Development Health IT Healthcare IT 69

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Digital Health Global

AUGUST 30, 2023

QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. According to a recent Deloitte article , ROI on pharma R&D has steadily declined, reaching 1.2

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Digital Health Global

SEPTEMBER 28, 2023

These are inspiring times for novel ideas to come to life , as new disruptive AI models reveal fresh insights from complex data and dramatically accelerate the application of research learning into future standards of care. The fund has already started its activity with two Seed investments, with two more to be announced soon.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS –(BUSINESS WIRE)– Medable Inc. , In 2024, expect to see more innovative technologies and new ways of delivering streamlined, patient-centric trials from Medable.”

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.

Life Science 88

Life Science BioTech Drug Development Health science 88

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Dr. Bernd Seizinger, M.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

DECEMBER 11, 2023

Health Tech founder and M&A Advisor Lloyd Price believes virtual care can bring a sweep of benefits, but cautions that it will still need to find a way through barriers around access and affordability for patients, the security of patient data and the licensing of healthcare providers to practice across geographical and care boundaries.

Pharmaceuticals 67

Pharmaceuticals Digital Health Drug Development Life Science 67

Lloyd Price

DECEMBER 8, 2018

Life-sciences companies recorded the strongest gains, Fenwick found, with their valuations rising 110% compared with their prior funding rounds. But key facets of its business didn’t develop as planned, say people familiar with the company.

Pharmaceuticals 57

Pharmaceuticals Life Science BioTech Drug Development 57

Lloyd Price

FEBRUARY 18, 2024

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Gain access to new technologies and data assets. Leverage data and analytics capabilities.

Pharmaceuticals 67

Pharmaceuticals healthcare technology Digital Health Remote care 67

Digital Health Global

MAY 21, 2024

The Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) will create the largest open data platform for ALS research Partnership will enable discovery and development of diagnostic tools, biomarkers, and better treatments NORTH BETHESDA, Md.–(BUSINESS

Life Science 88

Life Science Drug Development Digital Health Health Technology 88

Henry Kotula

MARCH 10, 2021

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

Life Science 41

Life Science Pharmaceuticals Drug Development EHR 41

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. It’s also not a secret that 3rd party data has huge implications as key social determinants of health (availability of healthy food at the grocery store, distance to a pharmacy etc.). Check out our community’s pharma predictions.

Health IT 85

Health IT Pharmaceuticals Drug Development Life Science 85

Healthcare IT Today

JANUARY 17, 2024

As behavioral health practitioners, we must make our voices heard from the very beginning of the generative AI conversation to bring the evidence-based data and experience to the conversation. Embrace the value while protecting the data. It is all too easy for non-clinicians to bear on what is a therapeutic clinical experience.

Health IT 103

Health IT Mental health Interoperability Patient Experience 103